| 摘要 |
of the Invention The invention is directed to a sterile, stable, multiple-dose pharmaceutical product for intravenous use consisting essentially of a non-preserved, ready-to-use solution of a salt of vincristine wherein the concentration of said vincristine in said solution is from about 0.50 mg/mL to about 2.0 mg/mL; wherein the pH of said solution is from about 5.5; and wherein said solution is contained in a multiple-dose unit container.
|
